Cargando…
Challenges of Diagnosing Antibody-Mediated Rejection: The Role of Invasive and Non-Invasive Biomarkers
Kidney transplantation is the best treatment modality for end-stage kidney disease, leading to improvement in a patient’s quality and quantity of life. With significant improvements in short-term outcomes, prolonging long-term allograft and patient survival remain ongoing challenges. The ability to...
Autores principales: | Krishnamoorthy, Sambhavi, Kyeso, Yousuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147623/ https://www.ncbi.nlm.nih.gov/pubmed/34063583 http://dx.doi.org/10.3390/medicina57050439 |
Ejemplares similares
-
Advances in diagnosing and managing antibody-mediated rejection
por: Jordan, Stanley C., et al.
Publicado: (2010) -
The therapeutic challenge of late antibody‐mediated kidney allograft rejection
por: Böhmig, Georg A., et al.
Publicado: (2019) -
The New Challenge in Pediatric Liver Transplantation: Chronic Antibody-Mediated Rejection
por: Uebayashi, Elena Yukie, et al.
Publicado: (2022) -
Non-invasive Biomarkers of Acute Rejection in Kidney Transplantation: Novel Targets and Strategies
por: Eikmans, Michael, et al.
Publicado: (2019) -
Non-invasive Chemokine Detection: Improved Prediction of Antibody-Mediated Rejection in Donor-Specific Antibody-Positive Renal Allograft Recipients
por: Mühlbacher, Jakob, et al.
Publicado: (2020)